Belluscura (LSE:BELL) Accounts Payable : £2.27 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura Accounts Payable?

Belluscura's Accounts Payable for the quarter that ended in Jun. 2024 was £2.27 Mil.

Belluscura's quarterly Accounts Payable declined from Jun. 2023 (£1.48 Mil) to Dec. 2023 (£0.52 Mil) but then increased from Dec. 2023 (£0.52 Mil) to Jun. 2024 (£2.27 Mil).

Belluscura's annual Accounts Payable increased from Dec. 2021 (£0.58 Mil) to Dec. 2022 (£2.09 Mil) but then declined from Dec. 2022 (£2.09 Mil) to Dec. 2023 (£0.52 Mil).

Belluscura Accounts Payable Historical Data

The historical data trend for Belluscura's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Accounts Payable Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.03

0.58

2.09

0.52

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable	Get a 7-Day Free Trial						2.39	2.09	1.48	0.52	2.27

Belluscura Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Belluscura Accounts Payable Related Terms

Thank you for viewing the detailed overview of Belluscura's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (LSE:BELL) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

9VQ:Germany

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company has only one operating segment being the sale of oxygen concentrators in the United States. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura Headlines

No Headlines